ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 117 filers reported holding ANAPTYSBIO INC in Q1 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $513,998 | -11.7% | 28,619 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $582,111 | -0.6% | 28,619 | +6.3% | 0.01% | 0.0% |
Q1 2023 | $585,714 | -27.6% | 26,917 | +3.1% | 0.01% | -31.2% |
Q4 2022 | $809,366 | +21.3% | 26,117 | +0.0% | 0.02% | +23.1% |
Q3 2022 | $667,000 | +39.0% | 26,110 | +10.6% | 0.01% | +44.4% |
Q2 2022 | $480,000 | -14.0% | 23,610 | +4.9% | 0.01% | +12.5% |
Q1 2022 | $558,000 | -36.4% | 22,509 | -10.7% | 0.01% | -27.3% |
Q4 2021 | $877,000 | -3.6% | 25,209 | -24.8% | 0.01% | -8.3% |
Q3 2021 | $910,000 | +77.7% | 33,514 | +70.0% | 0.01% | +100.0% |
Q2 2021 | $512,000 | +31.3% | 19,714 | +9.4% | 0.01% | +50.0% |
Q1 2021 | $390,000 | +41.3% | 18,013 | +40.6% | 0.00% | +33.3% |
Q4 2020 | $276,000 | +6.2% | 12,816 | -27.3% | 0.00% | 0.0% |
Q3 2020 | $260,000 | -34.0% | 17,618 | 0.0% | 0.00% | -40.0% |
Q2 2020 | $394,000 | +60.8% | 17,618 | +1.7% | 0.01% | +66.7% |
Q1 2020 | $245,000 | -18.3% | 17,321 | -5.9% | 0.00% | 0.0% |
Q4 2019 | $300,000 | – | 18,412 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $81,462,731 | 11.84% |
EcoR1 Capital, LLC | 7,521,024 | $233,076,534 | 7.09% |
5AM Venture Management, LLC | 357,733 | $11,086,146 | 2.98% |
Boxer Capital, LLC | 1,300,000 | $40,287,000 | 2.12% |
Frazier Life Sciences Management, L.P. | 899,700 | $27,881,703 | 1.73% |
Palo Alto Investors LP | 431,024 | $13,357,434 | 1.14% |
Logos Global Management LP | 250,000 | $7,747,500 | 0.91% |
BRAIDWELL LP | 726,122 | $22,502,521 | 0.75% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,161,826 | $36,004,988 | 0.74% |
Rock Springs Capital Management LP | 576,600 | $17,868,834 | 0.43% |